Immunopharmacol Immunotoxicol
December 2012
Objective And Design: We investigated the involvement of Th17 cells and T-cell immunoglobulin and mucin domain 3 (TIM-3) in Guillain-Barré syndrome (GBS) in comparison to healthy subjects.
Materials And Subjects: Peripheral blood samples were obtained from 29 healthy subjects and 29 GBS patients.
Treatment: Peripheral blood mononuclear cells (PBMCs) and CD4(+) T cells were stimulated with anti-CD3 and anti-CD28 mAbs, in the absence or presence of anti-TIM-3 mAb.